Search results for "death"

Il testamento biologico: dimensioni culturali, prospettive simboliche e psicodinamiche

2009

Recenti vicende umane e giuridiche hanno portato in primo piano il tema del testamento biologico e del rapporto tra l’uomo, la malattia e la morte. L’interrogativo sulla morte è connesso con quello della vita umana che viene considerata ora come la semplice sopravvivenza dell’organismo biologico, ora come un’esperienza che racchiude aspetti emotivi, affettivi e relazionali. Le discipline psicologiche possono aiutare a riflettere sul rapporto della società contemporanea con la malattia e con la morte, sui riti che accompagnano tali esperienze, sui processi decisionali che sottostanno al testamento biologico. Nell’epoca contemporanea la medicina si accosta al morente con l’idea di vincere la …

Forensic Microbiology: A Case Series Analysis

2019

The importance of microbial colonization of human organs in a living body has long been assessed. What still remains unclear are the microbial changes occurring after death, thus leading to the advent of a relatively novel field of research called “Postmortem microbiology”. It is applied to several forensic fields such as post-mortem interval assessment and cause of death determination. In this contest, a major limit is thus represented by the correct interpretation of the microbial data and by the actual lack of standard procedures. Here we propose a standard operative protocol in order to avoid false positives given by contamination (the main problem), post-mortem translocation and agonal…

LA MORTE IMPROVVISA CARDIACA DI TIPO ELETTRICO: ASPETTI ISTOPATOLOGICI DEL TESSUTO DI CONDUZIONE CARDIACO

In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study. Marengoni A,

2010

OBJECTIVE: The aim of the study was to recognize clusters of diseases among hospitalized elderly and to identify groups of patients at risk of in-hospital death and adverse clinical events according to disease clustering. METHOD: This was a cross-sectional study conducted in 38 internal medicine and geriatric wards in Italy participating in the Registro Politerapie SIMI (REPOSI) study during 2008. The subjects were 1,332 inpatients aged 65 years or older. Clusters of diseases (i.e., two or more co-occurrent diseases) were identified using the odds ratios (OR) for the associations between pairs of conditions, followed by cluster analysis. Logistic regression models were used to evaluate the …

Retrospective study on the comparison of out-of-hospital and in-hospital sudden cardiovascular death: An italian experience

2015

A retrospective study of forensic autopsies was carried out in the time interval January 2007 to December 2012 at the Forensic Pathology Service, Catania, south Italy, with a reference population of 3 000 000 inhabitants. During the study period, 1346 forensic autopsies were performed, including 223 (16.57%) sudden/unexpected deaths. Among the latter, 116 fulfilled the criteria of out-of-hospital (Group A) and 107 were in-hospital (Group B) sudden/unexpected deaths with suspected medical malpractice and/or a professional liability claim. In Group A, coronary artery disease was the most common cause of death (N=67; 57.65 %), followed by cardiomyopathies (N=19, 16.38%) and myocarditis (N= 6; …

Fetal and perinatal desths: drugs exposure duruing pregancy

2009

The presentation of this review will focus attention on the area of pediatric forensic medicine and the importance of through investigation of these deaths not only for the appropriate classification of the cause adn manner of deaths, but for complete documentation of toxicological data and pathological findings wich may provide essential informations about the circumstances surrounding the death and possible contributory mechanism.

SUDDEN UNEXPLAINED JUVENILE DEATH AND THE ROLE OF MEDICOLEGAL INVESTIGATION: UPDATE ON MOLECULAR AUTOPSY

2012

In the past few years, contributions of molecular biology assays to the investigation of sudden juvenile death have permitted to clarify some of the pathogenetic aspects of sud-den arrhythmic death, opening the way to preventive action on victims’ relatives. We reviewed literature on the genetics of sudden juvenile death, and on molecular biol-ogy assays performed on autoptic samples. Biological investigation permits the detection of genetic mutations underlying the suscep-tibility to sudden cardiac death of individuals with rare inherited forms of arrhythmia (Long QT Syndrome, Brugada Syndrome, Lev’s disease etc.) through the analysis of criti-cal sequences codifying for ion channel subuni…

Disentangling conditional effects of multiple regime shifts on Atlantic cod productivity

2020

AbstractRegime shifts are increasingly prevalent in the ecological literature. However, definitions vary, and many detection methods are subjective. Here, we employ an operationally objective means of identifying regime shifts, using a Bayesian online change-point detection algorithm able to simultaneously identify shifts in the mean and(or) variance of time series data. We detected multiple regime shifts in long-term (59-154 years) patterns of coastal Norwegian Atlantic cod (>70% decline) and putative drivers of cod productivity: North Atlantic Oscillation (NAO); sea-surface temperature; zooplankton abundance; fishing mortality (F). The consequences of an environmental or climate-relate…

Ceļš: Latvijas Universitātes Teoloģijas fakultātes teoloģisks, reliģijpētniecisks un kultūrvēsturisks izdevums, Nr.61

2011

Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma – an update

2020

CTLA-4 and PD-1 play a key role in tumor-induced downregulation of lymphocytic immune responses. Immune checkpoint inhibitors have been shown to alter the immune response to various cancer types. Anti-CTLA-4 and anti-PD-1 antibodies affect the interaction between tumor, antigen-presenting cells and T lymphocytes. Clinical studies of the anti-CTLA-4 antibody ipilimumab and the anti-PD-1 antibodies nivolumab and pembrolizumab have provided evidence of their positive effects on overall survival in melanoma patients. Combined treatment using ipilimumab and nivolumab has been shown to achieve five-year survival rates of 52 %. Such enhancement of the immune response is inevitably associated with …